Search This Blog

Friday, June 5, 2026

BioCardia: FDA minutes confirm CardiAMP HF II trial may support Premarket Approval

 BioCardia: FDA minutes confirm CardiAMP HF II trial may support Premarket Approval for CardiAMP Cell Therapy System in ischemic HFrEF

https://finviz.com/stock?t=BCDA&p=d

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.